CompletedPhase 2

A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101

United States3 participantsStarted 2021-10-19

Plain-language summary

Safety and tolerability study of 2 concentrations of QLS-101 for adult subjects with Sturge Weber Syndrome (SWS)-related glaucoma due to elevated episcleral venous pressure (EVP).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with SWS. * Elevated intraocular pressure (IOP) * Willing to continue current dosing regimen of IOP-lowering medications * Willing to refrain from contact lens use in the study eye. Exclusion Criteria: * IOP with variability of \> 4 mm Hg * Expected to undergo IOP-lowering surgery * Incisional or laser surgery of any type * Ocular infection, inflammation, clinically significant blepharitis or conjunctivitis * A history of herpes simplex keratitis in either eye. * History of or active clinically significant ocular disease * Use of topical ocular corticosteroids in the 6 weeks prior to Visit 1